Multiple Sclerosis Association of America http://www.mymsaa.org
National Multiple Sclerosis Society http://www.nationalmssociety.org
Health Canada http://www.hc-sc.gc.ca
Multiple Sclerosis Society of Canada http://mssociety.ca
Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis.
Lancet Neurol. 2010;9(6):599-612.
Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
N Engl J Med. 2010;362(5):402-415.
FDA approves Ampyra to improve walking in adults with multiple sclerosis. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm198463.htm. Updated April 25, 2013. Accessed August 28, 2015.
FDA approves first oral drug to reduce MS relapses. US Food and Drug Administration website. Available at:
Updated April 19, 2013. Accessed August 28, 2015.
International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, et al. Risk alleles for multiple sclerosis identified by a genomewide study.
N Engl J Med.
Kang JH, Sheu JJ, Kao S, Lin HC. Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study.
J Infect Dis.
Kasper DL, Braunwald E, et al.
Harrison’s Principles of Internal Medicine. 16th ed. The McGraw-Hill Companies; 2006.
Kappos L, Radue EW. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
N Eng J Med. 2010;362(5):387-401.
Multiple sclerosis. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T116285/Multiple-sclerosis-MS. Updated March 4, 2016. Accessed September 26, 2016.
NINDS multiple sclerosis information page.
National Institute of Neurological Disorders and Stroke
website. Available at:
Updated July 17, 2015. Accessed August 28, 2015.
Rose JW, Carlson NG. Pathogenesis of multiple sclerosis.
Continuum Lifelong Learning Neurol.
Treating MS. National Multiple Sclerosis Society. Available at
http://www.nationalmssociety.org/Treating-MS. Accessed August 28, 2015.
What is MS?
National Multiple Sclerosis Society website. Available at:
http://www.nationalmssociety.org/What-is-MS. Accessed August 28, 2015.
Van der Mae IA, Simpson S Jr, Stankovich J, Taylor BV. Individual and joint action of environmental risk factors and MS.
Neurol Clin. 2011;29(2):233-55.
1/4/2011 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T116285/Multiple-sclerosis-MS: Healy B, Ali E, Guttmann C, et al. Smoking and disease progression in multiple sclerosis.
4/25/2014 DynaMed Plus Systematic Literature Surveillance http://www.dynamed.com/topics/dmp~AN~T905969/Treatment-of-specific-impairments-in-multiple-sclerosis: Rosti-Otajärvi EM, Hämäläinen PI.
Neuropsychological rehabilitation for multiple sclerosis.
Cochrane Database Syst Rev. 2014;2:CD009131.
4/25/2014 DynaMed Plus Systematic Literature Surveillance http://www.dynamed.com/topics/dmp~AN~T116285/Multiple-sclerosis-MS: Yadav V, Bever C Jr, Bowen J, et al. Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(12):1083-1092.
11/9/2015 DynaMed Plus Systematic Literature Surveillance http://www.dynamed.com/topics/dmp~AN~T116285/Multiple-sclerosis-MS: Kuo CF, Grainge MJ, Valdes AM, et al. Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern Med. 2015;175(9):1518-1526.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
It's time to stop guessing. If you want to make some changes but just aren't sure how, the free personal health survey from LiveWell is a great place to start.
Fight heart disease and prevent heart attacks. HeartSHAPE® is a painless, non-invasive test that checks pictures of your heart for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.